Opendata, web and dolomites

Miiskin SIGNED

ML-powered app and platform to identify skin changes over time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Miiskin project word cloud

Explore the words cloud of the Miiskin project. It provides you a very rough idea of what is the project "Miiskin" about.

reduce    quality    teledermatology    denmark    98    norway    countries    cancer    app    poles    miiskin    mostly    market    node    clinical    photo    artificial    made    position    highest    2030    manually    expansion    mm    risk    25    232    melanoma    diagnosed    moles    concentrated    automatic    minimum    bearing    africa    innovation    tool    nevertheless    efficient    deaths    previously    survival    innovative    tumour    supporting    monitor    diagnose    intelligence    body    people    lymphatic    treating    metastases    helping    time    250    lacking    successful    unlocking    dermatologically    commercial       spotting    rate    mortality    ambition    doctor    apps    responsible    worldwide    healthcare    mole    melapp    endorsement    globally    australia    monitoring    close    identification    certification    malignant    competitive    south    consuming    seal    originates    detection    thanks    patient    sign    unprecise          skinvision    treatment    healthy    acquired    skin    created    caused    400    melanocytes   

Project "Miiskin" data sheet

The following table provides information about the project.

Coordinator
MIISKIN APS 

Organization address
address: FRUEBJERGVEJ 3
city: København O
postcode: 2100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MIISKIN APS DK (København O) coordinator 50˙000.00

Map

Leaflet | Map data © OpenStreetMap contributors, CC-BY-SA, Imagery © Mapbox

 Project objective

Malignant Melanoma (MM) is a tumour which originates mostly in the skin melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of lymphatic metastases and expansion to other areas of the body. Globally, 232,000 people are diagnosed with MM every year, 90,000 of those concentrated in Europe. While early detection of melanoma has a 98% survival rate, late detection has only a 10-25% survival rate, with a mortality rate going from 3% in countries like Norway or Denmark to 6-7% in other areas close to the poles like South Africa or Australia. Treating MM cost to the healthcare system a minimum of €10,000 to €250,000€ per patient. People at high risk of developing MM or healthy people who has previously been diagnose with MM skin cancer have to regularly monitor their skin and moles for changes. Any skin/mole change can be an early sign of skin cancer and early detection of melanoma is crucial for successful treatment. Nevertheless, the process of spotting manually new changes in the skin can be highly time consuming and unprecise, as it is done manually or using commercial apps (MelApp, SkinVision) lacking clinical certification. We have created, Miiskin app as a supporting tool to help users to monitor skin changes over time with an innovative technology application based in artificial intelligence. Thanks to our innovation, we made the monitoring process more efficient and reliable, helping in the identification of new moles through automatic photo comparison. Moreover, Miiskin will be used as patient-doctor node fully unlocking the potential of teledermatology. Thanks to that we are the unique app worldwide bearing the dermatologically endorsement quality seal. We have already acquired a strong and highly competitive market position as well as the highest rate among Skin Cancer apps, involving more than 400,000 users worldwide. With this ambition we aim to reduce skin cancer mortality to 1% by 2030.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIISKIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIISKIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

B2BMarketplace (2019)

The first B2B marketplace for Fast Moving Consumer Goods, connecting all brand manufacturers and retailers globally

Read More  

SiC-MOSFET (2019)

Gas Sensors for future Ultra Low NOx Emission Legislation – Euro 7

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More